Detalhe da pesquisa
1.
Effects of Jak2 type 1 inhibitors NVP-BSK805 and NVP-BVB808 on Jak2 mutation-positive and Bcr-Abl-positive cell lines.
Acta Haematol
; 132(1): 75-86, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24504330
2.
Clinical cardiac safety profile of nilotinib.
Haematologica
; 97(6): 883-9, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22271904
3.
Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia.
Thyroid
; 20(11): 1209-14, 2010 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-20929406
4.
Long-term follow-up of patients with Philadelphia chromosome-positive chronic myeloid leukemia after stem cell mobilization under imatinib.
Leuk Lymphoma
; 52(3): 517-20, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21133719